3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Sarcoma, Ewing's: new trials by email Literature Review of Sarcoma, Ewing's trials Research Report on Sarcoma, Ewing's
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors nab-paclitaxel - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Completed | Celgene | 107 | 2013-12-04 | 2019-12-27 |
| Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors CP-751,871 - Sarcoma, Ewing's | Phase 1 | Completed | Pfizer | 65 | 2005-08-01 | 2013-12-17 |
| A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16 - Neuroectodermal Tumor, Primitive, Neuroepithelioma | Phase 1 | Completed | National Cancer Institute (NCI) | 120 | 1986-10-01 | 2008-03-04 |
Sarcoma, Ewing (3) · Osteosarcoma (2) · Sarcoma (2) · Dermatofibrosarcoma (1) · Fibrosarcoma (1) · Histiocytoma (1) · Melanoma (1) · Neoplasms (1) · Neuroblastoma (1) · Neuroectodermal Tumors (1) · Neuroectodermal Tumors, Primitive (1) · Rhabdomyosarcoma (1)
Neoplasms by Histologic Type (3) · Neoplasms, Bone Tissue (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Myosarcoma (1) · Neoplasms by Site (1) · Neoplasms, Fibrous Tissue (1) · Neoplasms, Muscle Tissue (1) · Neuroectodermal Tumors (1) · Neuroectodermal Tumors, Primitive (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Cyclophosphamide (1) · Doxorubicin (1) · Vincristine (1) · figitumumab (1)
Celgene (1) · National Cancer Institute (NCI) (1) · Pfizer (1)
United States (3) · United Kingdom (2) · Canada (1) · France (1) · Italy (1) · Spain (1) · Switzerland (1)